Viewing Study NCT03549351


Ignite Creation Date: 2025-12-24 @ 11:39 PM
Ignite Modification Date: 2026-01-05 @ 5:54 PM
Study NCT ID: NCT03549351
Status: TERMINATED
Last Update Posted: 2022-09-13
First Post: 2018-05-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival
Sponsor: University Hospital Heidelberg
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NCT-2018-0554
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View